KRAS and pancreatic neoplasm: YAP1 expression levels are associated with poor patient outcome and the squamous subtype in PDAC [201,202], with YAP acting to bypass KRAS dependency in pancreatic cancer cell lines [201], suggesting an ability to induce transcription of targets up-regulated on aberrant KRAS signalling.